Compare Medline Inc. Class A Common Stock (MDLN) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medline Inc. Class A Common Stock vs Xylem, Inc. — how do they compare? Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B), while Xylem, Inc. trades at $102.47 (market cap $23.77B). The key difference: Medline Inc. Class A Common Stock is the larger of the two by market cap, and Xylem, Inc. pays a 1.69% dividend while Medline Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Xylem, Inc. for 50 Days on average.
| MDLN | XYL | |
|---|---|---|
Market Cap | $31.10B | $23.77B |
Volume | 4,471,639 | 2,477,250 |
Sector | Health | Industrials |
52-Week High | $49.99 | $152.95 |
52-Week Low | $31.64 | $100.92 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $41.07B | $25.55B |
Dividend Yield | — | 1.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Xylem (XYL) trades at $101.99, down 2.48% today, amid bearish technical signals but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected October 27. Revenue grew from $5.5B in 2022 to $9.04B in 2025, while net income margin expanded to 10.59%. Recent acquisitions of Cornell Pump and Roper Pump strengthen industrial presence.
Outlook remains positive with 47.5% analyst buy ratings and $149.13 consensus price target, representing 46% upside. Key risks include China weakness and higher debt from recent note offerings. The stock offers value with P/E of 24.24 and consistent dividend payments, though technical indicators suggest near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medline Inc. Class A Common Stock
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
